nodes	percent_of_prediction	percent_of_DWPC	metapath
Repaglinide—PPARG—nephron—nephrolithiasis	0.061	0.32	CbGeAlD
Repaglinide—ALB—Scavenging of heme from plasma—AMBP—nephrolithiasis	0.0488	0.16	CbGpPWpGaD
Repaglinide—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.028	0.0555	CcSEcCtD
Repaglinide—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.0219	0.0436	CcSEcCtD
Repaglinide—CYP3A4—urine—nephrolithiasis	0.0218	0.115	CbGeAlD
Repaglinide—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.0209	0.0415	CcSEcCtD
Repaglinide—ALB—Binding and Uptake of Ligands by Scavenger Receptors—AMBP—nephrolithiasis	0.0195	0.0636	CbGpPWpGaD
Repaglinide—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.0168	0.0333	CcSEcCtD
Repaglinide—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.0167	0.0331	CcSEcCtD
Repaglinide—ABCC8—renal system—nephrolithiasis	0.0157	0.0823	CbGeAlD
Repaglinide—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.0154	0.0307	CcSEcCtD
Repaglinide—ABCC8—kidney—nephrolithiasis	0.0152	0.0796	CbGeAlD
Repaglinide—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.0151	0.0301	CcSEcCtD
Repaglinide—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.015	0.0299	CcSEcCtD
Repaglinide—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.015	0.0297	CcSEcCtD
Repaglinide—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.0149	0.0296	CcSEcCtD
Repaglinide—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.0148	0.0295	CcSEcCtD
Repaglinide—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.0143	0.0285	CcSEcCtD
Repaglinide—SLCO1B1—renal system—nephrolithiasis	0.0139	0.0728	CbGeAlD
Repaglinide—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0273	CcSEcCtD
Repaglinide—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0272	CcSEcCtD
Repaglinide—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.0135	0.0268	CcSEcCtD
Repaglinide—SLCO1B1—kidney—nephrolithiasis	0.0134	0.0704	CbGeAlD
Repaglinide—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.0132	0.0262	CcSEcCtD
Repaglinide—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.013	0.0257	CcSEcCtD
Repaglinide—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0243	CcSEcCtD
Repaglinide—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.0121	0.0241	CcSEcCtD
Repaglinide—PPARG—renal system—nephrolithiasis	0.012	0.0628	CbGeAlD
Repaglinide—Erythema—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0237	CcSEcCtD
Repaglinide—PPARG—kidney—nephrolithiasis	0.0116	0.0607	CbGeAlD
Repaglinide—Back pain—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0229	CcSEcCtD
Repaglinide—ABCC8—Regulation of insulin secretion—CHRM3—nephrolithiasis	0.0115	0.0375	CbGpPWpGaD
Repaglinide—KCNJ11—Regulation of insulin secretion—CHRM3—nephrolithiasis	0.0111	0.0364	CbGpPWpGaD
Repaglinide—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0212	CcSEcCtD
Repaglinide—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0209	CcSEcCtD
Repaglinide—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0202	CcSEcCtD
Repaglinide—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0202	CcSEcCtD
Repaglinide—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00973	0.0193	CcSEcCtD
Repaglinide—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00973	0.0193	CcSEcCtD
Repaglinide—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00953	0.0189	CcSEcCtD
Repaglinide—ABCC8—Integration of energy metabolism—CHRM3—nephrolithiasis	0.00903	0.0295	CbGpPWpGaD
Repaglinide—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00887	0.0176	CcSEcCtD
Repaglinide—KCNJ11—Integration of energy metabolism—CHRM3—nephrolithiasis	0.00876	0.0286	CbGpPWpGaD
Repaglinide—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00874	0.0174	CcSEcCtD
Repaglinide—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00857	0.017	CcSEcCtD
Repaglinide—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00832	0.0165	CcSEcCtD
Repaglinide—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00796	0.0158	CcSEcCtD
Repaglinide—CYP2C8—renal system—nephrolithiasis	0.00789	0.0414	CbGeAlD
Repaglinide—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00773	0.0154	CcSEcCtD
Repaglinide—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00769	0.0153	CcSEcCtD
Repaglinide—CYP2C8—kidney—nephrolithiasis	0.00763	0.04	CbGeAlD
Repaglinide—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00717	0.0143	CcSEcCtD
Repaglinide—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00689	0.0137	CcSEcCtD
Repaglinide—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00666	0.0132	CcSEcCtD
Repaglinide—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00619	0.0123	CcSEcCtD
Repaglinide—Rash—Hydrochlorothiazide—nephrolithiasis	0.00614	0.0122	CcSEcCtD
Repaglinide—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00613	0.0122	CcSEcCtD
Repaglinide—Headache—Hydrochlorothiazide—nephrolithiasis	0.0061	0.0121	CcSEcCtD
Repaglinide—ABCC8—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00596	0.0195	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00596	0.0195	CbGpPWpGaD
Repaglinide—SLCO1B1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.0059	0.0193	CbGpPWpGaD
Repaglinide—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00578	0.0115	CcSEcCtD
Repaglinide—SLCO1B1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00539	0.0176	CbGpPWpGaD
Repaglinide—SLCO1B1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00539	0.0176	CbGpPWpGaD
Repaglinide—CYP3A4—renal system—nephrolithiasis	0.00535	0.028	CbGeAlD
Repaglinide—ABCC8—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00531	0.0173	CbGpPWpGaD
Repaglinide—CYP3A4—kidney—nephrolithiasis	0.00517	0.0271	CbGeAlD
Repaglinide—ABCC8—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00486	0.0159	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00486	0.0159	CbGpPWpGaD
Repaglinide—SLCO1B1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00409	0.0134	CbGpPWpGaD
Repaglinide—SLCO1B1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00409	0.0134	CbGpPWpGaD
Repaglinide—SLCO1B1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.0038	0.0124	CbGpPWpGaD
Repaglinide—SLCO1B1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.0038	0.0124	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00368	0.012	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00368	0.012	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00342	0.0112	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00342	0.0112	CbGpPWpGaD
Repaglinide—SLCO1B1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00339	0.0111	CbGpPWpGaD
Repaglinide—ALB—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00337	0.011	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00336	0.011	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00336	0.011	CbGpPWpGaD
Repaglinide—ALB—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00308	0.0101	CbGpPWpGaD
Repaglinide—ALB—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00308	0.0101	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00305	0.00996	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00305	0.00996	CbGpPWpGaD
Repaglinide—CYP2C8—Biological oxidations—SLC26A1—nephrolithiasis	0.00304	0.00993	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.003	0.00979	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00274	0.00895	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00274	0.00895	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00244	0.00796	CbGpPWpGaD
Repaglinide—ALB—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00234	0.00763	CbGpPWpGaD
Repaglinide—ALB—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00234	0.00763	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.0022	0.0072	CbGpPWpGaD
Repaglinide—ALB—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00217	0.00709	CbGpPWpGaD
Repaglinide—ALB—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00217	0.00709	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—GRHPR—nephrolithiasis	0.00211	0.00691	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00208	0.00678	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00208	0.00678	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—GRHPR—nephrolithiasis	0.00205	0.0067	CbGpPWpGaD
Repaglinide—ALB—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00194	0.00632	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00193	0.00631	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00193	0.00631	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00192	0.00627	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00192	0.00627	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—AGXT—nephrolithiasis	0.00189	0.00616	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—AGXT—nephrolithiasis	0.00183	0.00597	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00172	0.00562	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00172	0.00562	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00171	0.00559	CbGpPWpGaD
Repaglinide—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.00163	0.00533	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—SLC26A1—nephrolithiasis	0.0016	0.00523	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—APRT—nephrolithiasis	0.0016	0.00523	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00157	0.00511	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00157	0.00511	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—APRT—nephrolithiasis	0.00155	0.00508	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—SLC26A1—nephrolithiasis	0.00155	0.00508	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—GRHPR—nephrolithiasis	0.00152	0.00495	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00138	0.00449	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—AGXT—nephrolithiasis	0.00135	0.00441	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GRHPR—nephrolithiasis	0.00119	0.0039	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00119	0.00388	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00119	0.00388	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—APRT—nephrolithiasis	0.00115	0.00375	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—SLC26A1—nephrolithiasis	0.00115	0.00375	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—AQP1—nephrolithiasis	0.00114	0.00373	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—DGKH—nephrolithiasis	0.00114	0.00371	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—SLC7A9—nephrolithiasis	0.00114	0.00371	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—AQP1—nephrolithiasis	0.00111	0.00362	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.0011	0.0036	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.0011	0.0036	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—AGXT—nephrolithiasis	0.00106	0.00347	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—CHRM3—nephrolithiasis	0.00103	0.00337	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—CHRM3—nephrolithiasis	0.001	0.00327	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000983	0.00321	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000983	0.00321	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—SLC26A1—nephrolithiasis	0.000905	0.00295	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—APRT—nephrolithiasis	0.000905	0.00295	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—AQP1—nephrolithiasis	0.000818	0.00267	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000786	0.00257	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CHRM3—nephrolithiasis	0.00074	0.00242	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GRHPR—nephrolithiasis	0.000686	0.00224	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GRHPR—nephrolithiasis	0.000682	0.00223	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—AQP1—nephrolithiasis	0.000645	0.0021	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—AGXT—nephrolithiasis	0.000611	0.002	CbGpPWpGaD
Repaglinide—ALB—Metabolism—AGXT—nephrolithiasis	0.000608	0.00199	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CHRM3—nephrolithiasis	0.000583	0.0019	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—SLC26A1—nephrolithiasis	0.00052	0.0017	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—APRT—nephrolithiasis	0.00052	0.0017	CbGpPWpGaD
Repaglinide—ALB—Metabolism—APRT—nephrolithiasis	0.000517	0.00169	CbGpPWpGaD
Repaglinide—ALB—Metabolism—SLC26A1—nephrolithiasis	0.000517	0.00169	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—AQP1—nephrolithiasis	0.00037	0.00121	CbGpPWpGaD
Repaglinide—ALB—Metabolism—AQP1—nephrolithiasis	0.000368	0.0012	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000368	0.0012	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CHRM3—nephrolithiasis	0.000335	0.00109	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CHRM3—nephrolithiasis	0.000333	0.00109	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.000328	0.00107	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—APRT—nephrolithiasis	0.000279	0.000911	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.000279	0.000911	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—AQP1—nephrolithiasis	0.000199	0.000649	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CHRM3—nephrolithiasis	0.00018	0.000587	CbGpPWpGaD
